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Dr. Tanya O. Bleiker 
Editor, British Journal of Dermatology 
 
Re: “Is thyrotropin-releasing hormone (TRH) a novel neuroendocrine 
modulator of keratin expression in human skin?”  
 
Enclosed, please find our manuscript entitled “Is thyrotropin-releasing hormone 
(TRH) a novel neuroendocrine modulator of keratin expression in human skin” 
for your consideration, which we submit for publication as a Concise 
Communication in the British Journal of Dermatology. The manuscript has not been 
published or submitted for publication elsewhere. All authors have contributed 
significantly and are in agreement with the content of the manuscript.   
 
In this report, we describe novel effects of the neurohormone, TRH, on the expression 
of selected human hair and epidermal keratins. While selected nuclear receptor 
hormones are appreciated to regulate specific keratins, very little is known about the 
neuroendocrine control of human keratin expression. Since preliminary microarray 
evidence from my lab had suggested that TRH may regulate keratin gene 
transcription, we have followed these pointers up in a pilot study, using organ cultures 
of microdissected, female scalp hair follicles and full-thickness human skin. 
 
The current study suggests that TRH is indeed a novel modulator of the expression of 
human hair and epithelial keratins in situ, thus identifying the neuroendocrine 
regulation of keratin expression as an exciting new research frontier in skin biology. 
Together with the recently identified stimulatory activity of TRH on mitochondrial 
activity, hair pigmentation and hair growth, the potent keratin expression-modulating 
effects of TRH revealed here may serve as a basis for novel therapeutic strategies that 
recruit neurohormones to modulate keratin expression in human skin and appendages.  
 
We thank you for your consideration of our manuscript and look forward to your 
reply.  
Best regards, 
Ralf Paus 
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What’s already known about this topic? 
• Although keratins are one of the major structural components of the hair fiber and 
skin epithelium, little is known about their hormonal influences. Since the role of 
neuropeptide hormones in the control of keratin expression remains largely 
obscure, we have followed preliminary microarray-based evidence which had 
suggested that thyrotropin-releasing hormone (TRH) may modulate keratin 
expression in human hair follicles.  
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What does this study add? 
• The current study provides evidence that the neuropeptide hormone TRH can act 
as a novel modulator of the expression of human hair and epithelial keratins in 
situ, thus identifying the neuroendocrine regulation of keratin expression as an 
exciting new research frontier in skin biology. 
• Together with the recently identified stimulatory activity of TRH on 
mitochondrial activity, hair pigmentation and hair growth, the potent keratin 
expression-modulating effects of TRH revealed here may serve as a basis for 
novel therapeutic strategies that recruit neurohormones to modulate keratin 
expression in human skin and appendages.  
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Summary 
Background Hair and epithelial keratins constitute the major structural components of 
the skin and its appendages, including the hair fiber. While selected steroid hormones 
are appreciated to regulate specific keratins, little is known about the neuroendocrine 
control of human hair keratin expression. Preliminary evidence had suggested that 
thyrotropin-releasing hormone (TRH) may regulate keratin gene transcription. 
Objective We wanted to clarify whether TRH operates as a novel neuroendocrine 
regulator of human hair and epithelial keratin expression under physiologically 
relevant conditions in situ. 
Methods Microdissected human female scalp hair follicles (HFs) and female scalp 
skin were treated in serum-free organ culture for 12h – 6d with 100ng/ml TRH or 
vehicle. Both quantitative immunohistomorphometry and RT-qPCR were utilized to 
assess expression of selected keratins.  
Results TRH significantly increased expression of the hair keratins K31 and K32, 
while that of K85 and K86, and of the epithelial keratins K14 and K17 was reduced. 
In the interfollicular epidermis, TRH stimulated expression of K6, K14 and K17, both 
at the mRNA and protein levels. Stimulation of the same keratins was also evident in 
the eccrine sweat and sebaceous glands.  
Conclusions Selected human hair and epithelial keratins are modulated in situ. This 
may be relevant to explain hair shaft growth-promoting effects of TRH. Our pilot 
study suggests that the neuroendocrine controls that regulate the expression of human 
keratins deserve more systematic exploration and that these may be harnessed 
therapeutically. 
Page 5 of 21 British Journal of Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Keratins are intermediate filaments, which exert vital functions in maintaining the 
homeostasis of the skin and its appendages.
1
 Their main role is to provide structural 
stability to the tissue, but recently it has been recognized that they might have a much 
wider spectrum of functions.
2
 Therefore, it is crucial to understand their regulatory 
mechanisms. While it is appreciated that nuclear receptor hormones such as thyroid 
hormones, glucocorticoids, calcitriol, and retinoids profoundly impact the expression 
of keratins and keratin-associated proteins in human skin,
3
 little is known on the 
neuroendocrine modulation of keratin expression in human skin, namely of 
neuropeptide hormones known to be generated in the skin itself. 
Interest in the neuroendocrine control of keratin expression in human skin has been 
invigorated by recent evidence that the neuropeptide hormone, prolactin, profoundly 
impacts on the expression of keratins such as K5, K6, K14, K15, K19 and K31 in 
human hair follicles (HFs).
4
 Thyroid stimulating hormone (thyrotropin, TSH) was 
also found to modulate keratin gene expression in the epidermis and HFs.
5,6
 This was 
underscored by preliminary gene profiling evidence that another neuropeptide 
hormone, thyrotropin-releasing hormone (TRH), which is also produced by HFs, may 
interfere and regulate selected intrafollicularly expressed keratins and keratin-
associated proteins.
7
  
Since TRH is a potent stimulator of human hair growth in situ,
7 
and also stimulates 
hair pigmentation,
8
 we wanted to elucidate whether TRH acts as a novel regulator of 
keratin expression in situ. This was studied on microdissected, organ-cultured female 
scalp HFs
8,9
 and interfollicular skin
10
 under serum-free conditions in the presence of 
insulin and hydrocortisone.
11
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Materials and methods 
Excess human scalp skin was obtained after written informed consent from 6 healthy 
females during cosmetic face lift surgery (after the University of Luebeck ethics 
committee approval), as previously described.
5,7
 HF mRNA extracts from two females 
were subjected to quantitative real-time PCR (RT-qPCR) for selected hair keratin 
genes after 12h or 24h treatment with TRH (100ng/ml) or vehicle. For 
immunohistochemical analysis, isolated HFs from an additional female volunteer 
were organ cultured for 6 days as described previously,
4,7
 and expression of selected 
keratins and Msx2 (muscle segment homeobox-like 2), a major transcription factor 
that regulates hair keratin expression
12
, was studied using the staining protocols 
described in Table 1. For RT-qPCR evaluation of epithelial keratins, total RNA was 
isolated from enzymatically separated human epidermis from an additional female 
volunteer, after 12h culture with 100ng/ml TRH or vehicle. For immunohistochemical 
analysis of epidermal keratins, skin from two additional different females was organ 
cultured for 4d with 100 ng/ml TRH or vehicle.  
 
Results 
Treatment with 100 ng/ml TRH for 6d significantly increased in situ the 
immunostaining intensity of the hair keratins K31 (hair cortex) and of K32 (hair 
cuticle). In contrast, staining intensity of the hair keratins K85 (precortical hair matrix 
and cuticle), and K86 (mid-to-upper hair cortex) was reduced by TRH. TRH also 
decreased staining intensity in situ of the epithelial keratins K14 and K17 in the outer 
root sheath (ORS) of the female anagen scalp HFs (Figure 1, A-F).  
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K31 transcription was decreased while K17 mRNA levels were increased by 
treatment with 100ng/ml TRH for 12h, as assessed by RT-qPCR (Figure 1, G). Since 
according to our previous TRH microarrays,
7
 K31 and K32, which represent the hair 
cortex and hair cuticle,
13
 respectively, were both found to be differentially regulated, 
and considering the importance of K85 as the earliest keratin expressed in the 
precortical hair matrix and early cuticle,
13
 we also checked their transcription in an 
additional patient (24h culture period). While mRNA levels of both K32 and K85 
were decreased, K31 transcription was unchanged (Figure 1, H and Supplementary 
Table 1).   
In the epidermis, TRH profoundly increased staining intensity for keratins K14, K6 
and K17 after 4d of serum-free organ culture in the presence of 100ng/ml TRH 
(Figure 2, A-C). TRH also significantly stimulated K14 and K6 transcription, while a 
trend towards slightly increased K17 mRNA expression was observed, but did not 
reach significance (Figure 2, A-C). Finally, TRH also appeared to enhance K14, K6 
and K17 expression in the secretory and ductal parts of the eccrine sweat glands, 
including myoepithelial cells, and in the secretory part of the sebaceous glands 
(Figure 2, D-F).   
 
Discussion 
Our pilot study suggests that TRH is a potent, novel modulator of keratin expression 
in defined epithelial compartments of human skin. This confirms earlier preliminary 
gene profiling evidence,
7
 and suggests that keratins, namely K14, K17, K31, K32, 
K85 and K86, are (direct or indirect) targets of TRH regulation. Moreover, this study 
underscores that human skin and HF organ culture are instructive, clinically relevant 
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discovery tools for dissecting the neuroendocrine controls of human keratin 
expression in situ. However, especially in the HF, the puzzling mRNA and protein 
expression discrepancies observed after TRH stimulation in our pilot study warrant 
systematic follow-up work to clarify the exact effect of TRH on human keratin 
expression in situ (for additional discussion, see supplementary text 1). 
The mechanism(s) by which TRH affects expression of these keratins remains 
presently unclear. Msx2, i.e. one reasonable candidate transcription factor that might 
have been involved in mediating these effects
12
 did not respond to TRH stimulation 
on the mRNA and protein levels (see Supplementary Table 1). Moreover, prominent 
TRH receptor (TRH-R) protein expression in human anagen HFs is restricted to the 
inner root sheath.
7,8
 Therefore, it is conceivable that the keratin expression-regulatory 
effects of TRH outside of the inner root sheath are not directly mediated via TRH-R 
stimulation. Since TRH upregulates intraepidermal TSH expression in human 
epidermis,
10
 some of the keratin effects of TRH may actually be mediated by 
promoting the intraepithelial production of TSH. In fact, TSH administration to 
cultured human HFs modulates expression of several keratins in a somewhat 
comparable manner as TRH, such as K14, K17 and K85.
6
  
Following the recent development of novel TRH analogs, which are metabolically 
stable, and are currently in different stages of preclinical or clinical development,
14
 it 
becomes clinically important to understand whether such analogs might have an effect 
on skin, and on possible endocrine interactions between intracutaneous production of 
neurohormones and external TRH application.  
In summary, our pilot study reveals yet another important frontier in the ongoing 
quest to explore of the hypothalamus-pituitary-thyroid axis equivalent of human 
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skin:
15
 the differential neuroendocrine regulation of selected sets of keratins in distinct 
epithelial tissue compartments by TRH.  
 
 
 
Figure legends 
 
Figure 1. TRH (100 ng/ml) regulates expression of K31 (A), K32 (B), K85 (C), K86 
(D), K14 (E) and K17 (F) in microdissected, organ-cultured, normal female scalp skin 
HFs, after 6d of administration, as documented by immunostaining intensity. 
Microarray analysis has previously shown that several genes are regulated in organ-
cultured human hair follicles at this time point and dose.
7,9
 The staining pattern of 
selected keratins precisely corresponds to the previously reported pattern; see Table 1 
for details. Staining intensities were measured in defined reference areas by 
quantitative immunohistomorphometry using ImageJ software (NIH, Bethesda, MD, 
USA; http://rsbweb.nih.gov/ij/) as previously described. Columns represent 
means±SEM ; n=15–18 HFs/group. P<0.05 vs. Control, **P<0.01, ***P<0.001; 
unpaired two-tailed Student's t-test. Scale bars: 50 µm. For recognized standard 
keratin expression patterns in human HFs see Langbein et al., 2005
13
 and Moll et al., 
2007.
1
 (G, H) Relative mRNA expression following administration of TRH to HFs in 
culture for 12h (G) or 24h (H), extracted from HFs of additional two patients. TRH 
did not significantly alter mRNA levels of the other keratins (K14, K32, K85 and 
K86) evaluated during the short 12h incubation time (Supplementary Table 1). In 
addition, MSX2 expression, a transcription factor important for keratin regulation,
6,12
 
was not affected by TRH, both at protein and mRNA levels (Supplementary Table 1). 
Results represent triplicate determinations of samples. Total RNA was pooled from 20 
HFs. **P<0.01; mean ±SEM. Statistical analysis was performed by two-tailed 
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Student's t-test. PCR amplification was carried out by using the TaqMan primers and 
probes (Assay IDs: Hs00356958_m1 for K17, Hs00605539_m1 for K31, 
Hs00605543_g1 for  K32 and Hs00158558_m1 for  K85) using the TaqMan 
Universal PCR Master Mix Protocol (Applied Biosystems). As internal controls, 
transcripts of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined 
(Assay ID: Hs99999905_m1 for GAPDH). 
 
Figure 2. TRH (100 ng/ml) upregulates expression of K14 (A, D), K6 (B, E) and K17 
(C, F) in several skin compartments, including epidermis (semi-quantitative 
evaluation using ImageJ), sweat glands and sebaceous glands (visual evaluation). 
Columns represent means±SEM; n = 2 different experiments. Statistical analysis was 
performed by two-tailed Student's t-test. Relative mRNA expression of KRT6, KRT14 
and KRT17 in enzymatically dissected epidermal cells after 12h organ culture with 
TRH (100 ng/ml), showed increased mRNA levels of K6 and K14, but no statistically 
significant change in K17 mRNA levels (A-C). ***P<0.001; mean ±SEM. PCR 
amplification was carried out by using the TaqMan primers and probes (Assay IDs: 
Hs01699178_g1 for K6, Hs00265033_m1 for K14, and Hs00356958_m1 for K17) 
using the TaqMan Universal PCR Master Mix Protocol (Applied Biosystems). As 
internal controls, transcripts of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
were determined (Assay ID: Hs99999905_m1 for GAPDH). 
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TABLE 1. Primary antibodies used 
 
Expression site Host Dilution Source 
Clone/ 
antiserum 
Protein 
 
Inner layers of the ORS; companion layer; suprabasal layers of wounded skin; ductal 
luminal cells of eccrine sweat glands
1,6,13
 
Mouse 1:10 PROGEN, Heidelberg, Germany Ks6.KA12 Keratin K6 
 
Skin epidermis, basal layer; all layers of the ORS
1,6,13
 Mouse 1:50 
Sigma-Aldrich, Taufkirchen, 
Germany 
CKB1 Keratin K14 
 
Inner layers of the ORS, companion layer; suprabasal layers of wounded skin, sweat 
glands, sebaceous glands1 
Mouse 1:50 PROGEN, Heidelberg, Germany Ks17.E3 Keratin K17 
 
Hair fiber precortex/cortex 6,13 
Guinea 
Pig 
1:7000 
Lutz Langbein, DKFZ, 
Heidelberg, Germany 
hHa1 
prot.1 
Keratin K31 
 
Hair fiber cuticle
6
 
Guinea 
Pig 
1:2000 
Lutz Langbein, DKFZ, 
Heidelberg, Germany 
Ha2.1 Keratin K32 
 
Hair fiber matrix, cortex and cuticle
1,6
 
Guinea 
Pig 
1:1000 
Lutz Langbein, DKFZ, 
Heidelberg, Germany 
hHb 5co.2 Keratin K85 
 
Hair fiber cortex
1
 
Guinea 
Pig 
1:2000 
Lutz Langbein, DKFZ, 
Heidelberg, Germany 
hHb 6-1 Keratin K86 
 
Hair fiber matrix and cortex
6
 Goat 1:100 Santacruz, CA, USA - Msx-2 
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Figure 1. TRH (100 ng/ml) regulates expression of K31 (A), K32 (B), K85 (C), K86 (D), K14 (E) and K17 (F) 
in microdissected, organ-cultured, normal female scalp skin HFs, after 6d of administration, as documented 
by immunostaining intensity. Microarray analysis has previously shown that several genes are regulated in 
organ-cultured human hair follicles at this time point and dose.7,9 The staining pattern of selected keratins 
precisely corresponds to the previously reported pattern; see Table 1 for details. Staining intensities were 
measured in defined reference areas by quantitative immunohistomorphometry using ImageJ software (NIH, 
Bethesda, MD, USA; http://rsbweb.nih.gov/ij/) as previously described. Columns represent means±SEM ; 
n=15–18 HFs/group. P<0.05 vs. Control, **P<0.01, ***P<0.001; unpaired two-tailed Student's t-test. 
Scale bars: 50 µm. For recognized standard keratin expression patterns in human HFs see Langbein et al., 
200513 and Moll et al., 2007.1 (G, H) Relative mRNA expression following administration of TRH to HFs in 
culture for 12h (G) or 24h (H), extracted from HFs of additional two patients. TRH did not significantly alter 
mRNA levels of the other keratins (K14, K32, K85 and K86) evaluated during the short 12h incubation time 
(Supplementary Table 1). In addition, MSX2 expression, a transcription factor important for keratin 
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regulation,6,12 was not affected by TRH, both at protein and mRNA levels (Supplementary Table 1). Results 
represent triplicate determinations of samples. Total RNA was pooled from 20 HFs. **P<0.01; mean ±SEM. 
Statistical analysis was performed by two-tailed Student's t-test. PCR amplification was carried out by using 
the TaqMan primers and probes (Assay IDs: Hs00356958_m1 for K17, Hs00605539_m1 for K31, 
Hs00605543_g1 for  K32 and Hs00158558_m1 for  K85) using the TaqMan Universal PCR Master Mix 
Protocol (Applied Biosystems). As internal controls, transcripts of glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) were determined (Assay ID: Hs99999905_m1 for GAPDH).  
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Figure 2. TRH (100 ng/ml) upregulates expression of K14 (A, D), K6 (B, E) and K17 (C, F) in several skin 
compartments, including epidermis (semi-quantitative evaluation using ImageJ), sweat glands and 
sebaceous glands (visual evaluation). Columns represent means±SEM; n = 2 different experiments. 
Statistical analysis was performed by two-tailed Student's t-test. Relative mRNA expression of KRT6, KRT14 
and KRT17 in enzymatically dissected epidermal cells after 12h organ culture with TRH (100 ng/ml), showed 
increased mRNA levels of K6 and K14, but no statistically significant change in K17 mRNA levels (A-C). 
***P<0.001; mean ±SEM. PCR amplification was carried out by using the TaqMan primers and probes 
(Assay IDs: Hs01699178_g1 for K6, Hs00265033_m1 for K14, and Hs00356958_m1 for K17) using the 
TaqMan Universal PCR Master Mix Protocol (Applied Biosystems). As internal controls, transcripts of 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined (Assay ID: Hs99999905_m1 for 
GAPDH).  
205x189mm (300 x 300 DPI)  
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Supplementary text 1:  
That TRH potently stimulates hair shaft elongation
1
 is supported in our pilot study by 
showing that TRH stimulates expression of the important, proximally expressed hair 
keratins K31 and K32 (Figure 1, B and C). Intriguingly, ORS keratins and more 
distally expressed hair keratins were found to be downregulated by TRH. This 
suggests that TRH exerts complex, differential regulatory effects on distinct subsets of 
human hair and epithelial keratins in situ, which deserve systematic exploration. In 
this context, it is notable that human skin and ORS keratinocytes in situ, express TRH 
at the mRNA and protein levels.
1,2
 Therefore, while these remain to be formally 
demonstrated, auto- and paracrine regulatory effects of TRH on the expression of 
selected keratins should be conceivable.  
In normal human epidermis, TRH strongly stimulated K14, expressed in basal and 
lower supra-basal keratinocytes, and of K6 and K17, expressed in hyperproliferative 
epidermis, companion layer and ORS keratinocytes. All of these, including keratin 6, 
are up-regulated/overexpressed or functionally important under wound healing 
conditions.
3,4
 Moreover, wound healing and the hair follicle cyling anagen phase 
share a number of common important biological features,
5
 and both are stimulated by 
TRH.
1
 Therefore, these keratin-upregulatory effects of TRH are in line with the 
anagen- and wound healing promoting properties of this intraepithelially produced 
tripeptide neurohormone, which may serve as an important neuroendocrine 
coordinator of epithelial tissue remodelling and regeneration. This is also consistent 
with the upregulation of the epidermal keratins, suggesting an overall stimulatory 
effect of TRH on epidermal cells, which recruits the mitochondria for, among others, 
upregulating expression of selected keratins.   
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While TRH regulation of keratins K6, K14, and K85 staining intensity in situ was 
confirmed on the transcript level, keratins K17 (in the HF), K31 and K32 transcription 
showed an opposite trend. A summary of available data on TRH regulatory effects at 
the mRNA and protein levels on selected keratins and MSX2 is reported in 
Supplementary Table 1. This discrepancy between the mRNA and protein data could 
be related to the greatly different lengths of organ culture (protein expression: 4 or 6 
days; qRT-PCR: 12 or 24 hours) as well as to individual characteristics of protein 
and/or mRNA processing and turnover for these specific keratins as cytoskeletal 
proteins. In addition, in the current pilot study, only a very limited number of human 
skin fragments was available for organ culture so that definitive conclusions on how 
TRH regulates expression of any of these keratins on the gene and protein level in situ 
should be reserved until independent repeat experiments with tissue from additional 
patients has been performed (since there is rapid RNA degradation in HF organ 
cultures, qRT-PCR was performed at 12 or 24 hours). The discrepancy between 
protein and transcription makes it difficult to draw definitive conclusions on whether 
TRH up- or downregulates intrafollicular expression of these keratins. However, our 
data available from this pilot study suggest that these keratins are regulated by TRH. 
It is also evident that there are large inter-individual differences in response to TRH, 
which in part might be related to age differences between the subjects examined (see 
Supplementary Table 1), and the protein and qRT-PCR data are never from the same 
patient. 
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Supplementary Table 1. TRH modifies keratin and MSX2 gene expression in human female 
scalp HFs 
Analysis  Microarray 1 Microarray 2 qRT-PCR 1 qRT-PCR 2 IF 
Age 55 years 62 years 47 years 49 years 66 years 
Location on 
scalp 
Fronto-
temporal 
Fronto-
temporal 
Fronto-
temporal 
Fronto-
temporal 
Fronto-
temporal 
Treatment 
time 
24 hours 24 hours 12 hours 24 hours 4 days 
K6 NC NC NC - - 
K14 ↓ ↓ NC - ↓ 
K16 ↓ ↓ - - - 
K17 ↓ NC ↑ - ↓ 
K31
a
 ↓ ↓ ↓ NC ↑ 
K32 ↓ ↓ NC ↓ ↑ 
K33a ↓ ↓ - - - 
K33b ↓ NC - - - 
K34 ↓ ↓ - - - 
K35
a
 ↓ ↓ NC - - 
K36 NC NC - - - 
K37 ↓ ↓ NC - - 
K81 ↓ NC - - - 
K82 NC ↓ - - - 
K83 ↓ NC - - - 
K84 NC NC - - - 
K85 ↓ NC NC ↓ ↓ 
K86
a
 ↓ ↓ - - ↓ 
MSX2 NC NC NC - NC 
aData appear in Gaspar et al., 2010, FASEB J.  
IF, immunofluorescence; NC, not changed; -, not investigated.  
In bold, microarray genes that were evaluated in at least one additional method.  
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